All Posts By

Florence

Global Virus Network Adds Tulane University School of Medicine as Newest Center of Excellence

By | Centers of Excellence, News | No Comments

Baltimore, Maryland, USA, and Atlanta, GA, USA, Oct. 19, 2016: The Global Virus Network (GVN) and Tulane University School of Medicine announced today the induction of Tulane as GVN’s newest Center of Excellence. The GVN represents 38 Centers of Excellence and six affiliates in 25 countries and comprises foremost experts in every class of virus causing disease in humans.

The announcement was made by Robert Gallo, MD, co-founder and scientific director of GVN and Robert Garry, PhD, professor, Department of Microbiology and Immunology, assistant dean, Graduate Program in Biomedical Sciences, program manager, Viral Hemorrhagic Fever Consortium, Tulane University School of Medicine. Garry will be director of Tulane’s GVN Center of Excellence.

The new Tulane GVN Center of Excellence focuses on a number of aspects of viral pathogenesis. Tulane also leads the Viral Hemorrhagic Fever Consortium (VHFC), a public-private partnership of scientists who are developing countermeasures, including diagnostics, immunotherapeutics and vaccines, against Lassa virus, Ebola and Marburg viruses, flaviviruses (including Zika virus) and several other high consequence pathogens.

“Given their breadth and deep expertise in viruses, particularly hemorrhagic viruses, Tulane will be an excellent resource for the GVN,” said Gallo, who is co-discoverer of HIV and The Homer and Martha Gudelsky Distinguished Professor in Medicine, director, Institute of Human Virology, University of Maryland School of Medicine, a GVN Center of Excellence. “Bob Garry’s ability to establish successful public-private partnerships, such as the VHFC, to help bring lab research to the clinic, particularly in the field of diagnostics, will be a tremendous boost to the GVN.”

“We look forward to joining the GVN so that we can better foster infrastructure development, research, training and education on detection, prevention, amelioration, and treatment of viral hemorrhagic fever viruses targeting both the scientific and general communities,” says Garry. “We have a significant presence in West Africa and are pleased to extend our global reach through the GVN.”

The VHFC is a collaboration between Tulane, Scripps Research Institute (a GVN Center of Excellence), Harvard University/Broad Institute, University of Texas Medical Branch (a GVN Center of Excellence), Autoimmune Technologies LLC, Kenema Government Hospital (Sierra Leone), Redeemers University and the Irrua Specialist Teaching Hospital (Nigeria), Zalgen Labs, LLC, and various other partners in West Africa.

The GVN is a global authority and resource for the identification and investigation, interpretation and explanation, control and suppression, of viral diseases posing threats to mankind. It enhances the international capacity for reactive, proactive and interactive activities that address mankind-threatening viruses and addresses a global need for coordinated virology training, developing scholarly exchange programs for recruiting and training young scientists in medical virology. The GVN also serves as a resource to governments and international organizations seeking advice about viral disease threats, prevention or response strategies and GVN advocates for research and training on virus infections and their many disease manifestations.

About the Global Virus Network (GVN)

The Global Virus Network (GVN) is a non-profit, 501(c)(3) organization, comprised of leading medical virologists from 25 countries. The GVN’s mission is to combat current and emerging pandemic viral threats through international collaborative research, training the next generation of medical virologists, and advocacy. For more information, please visit www.gvn.org. Follow us on Twitter @GlobalVirusNews

About Tulane University School of Medicine

One of the nation’s most recognized centers for medical education, Tulane University School of Medicine is a vibrant center for education, research and public service. Tulane School of Medicine is the second-oldest medical school in the Deep South and the 15th oldest medical school in the United States. Tulane School of Medicine recruits top faculty, researchers and students from around the world, and pushes the boundaries of medicine with groundbreaking medical research and surgical advances. Tulane remains in the forefront of modern medical innovation and is equipping the next generation of medical professionals with the tools to succeed in the rapidly changing future of health care.

Global Virus Network Adds International Vaccine Institute (IVI)

By | News | No Comments

Global Virus Network Adds International Vaccine Institute (IVI)

as Newest Center of Excellence

Baltimore, Maryland, USA, August 8, 2016: The Global Virus Network (GVN), representing 36 Centers of Excellence and 6 Affiliates in 25 countries and comprising foremost experts in every class of virus causing disease in humans, and the International Vaccine Institute (IVI) announced today the induction of IVI as GVN’s newest Center of Excellence. IVI is headquartered on the campus of Seoul National University in Seoul, South Korea. The announcement was made by Robert Gallo, MD, Co-Founder and Scientific Director of GVN and Jerome Kim, MD, Director General of IVI. IVI is the first organization in Korea to become a GVN Center of Excellence.

“IVI, with Dr. Jerome Kim at the helm, brings to the GVN an array of viral expertise, including HIV, Dengue, MERS-CoV and hepatitis E as well as a significant global reach with its field sites in nearly 30 countries in Asia, Africa and South America,” said Dr. Gallo, who is co-discoverer of HIV and Director of the Institute (IHV) of Human Virology at the University of Maryland School of Medicine, a GVN Center of Excellence. “GVN is very pleased to welcome IVI into the network and looks forward to officially introducing IVI to GVN’s Centers of Excellence at our upcoming international meeting in Japan this fall.”

The International Vaccine Institute (IVI) is an international nonprofit organization that was founded on the belief that the health of children in developing countries can be dramatically improved by the use of new and improved vaccines. Working in collaboration with the international scientific community, public health organizations, governments, and industry, IVI is involved in all areas of the vaccine spectrum – from new vaccine design in the laboratory to vaccine development and evaluation in the field to facilitating sustainable introduction of vaccines in countries where they are most needed.

“IVI wishes to gain opportunities in information-sharing and collaborations on research and training initiatives with GVN members,” said Dr. Kim. “We especially look forward to participating in scientific exchanges, and fellows and training programs.”

The GVN is a global authority and resource for the identification and investigation, interpretation and explanation, control and suppression, of viral diseases posing threats to mankind. It enhances the international capacity for reactive, proactive and interactive activities that address mankind-threatening viruses and addresses a global need for coordinated virology training, developing scholarly exchange programs for recruiting and training young scientists in medical virology. The GVN also serves as a resource to governments and international organizations seeking advice about viral disease threats, prevention or response strategies and GVN advocates for research and training on virus infections and their many disease manifestations.

About the Global Virus Network (GVN)

The Global Virus Network (GVN) is a non-profit, 501(c)(3) organization, comprised of leading medical virologists from 25 countries. The GVN’s mission is to combat current and emerging pandemic viral threats through international collaborative research, training the next generation of medical virologists, and advocacy. For more information, please visit www.gvn.org. Follow us on Twitter @GlobalVirusNews

 

About the International Vaccine Institute (IVI)

 

The International Vaccine Institute (IVI) is the world’s only international organization devoted exclusively to developing and introducing new and improved vaccines to protect the world’s poorest people, especially children in developing countries. Established in 1997, IVI operates as an independent international organization under a treaty signed by 35 countries and the World Health Organization. The Institute conducts research in more than 20 countries of Asia, Africa and Latin America on vaccines against enteric and diarrheal infections, Japanese encephalitis, MERS-CoV, and dengue fever, and develops new and improved vaccines at its headquarters in Seoul, Republic of Korea. For more information, please visit http://www.ivi.int.

GVN Symposium on the Global Spread of Chikungunya

By | News | No Comments

GVN Symposium on the Global Spread of Chikungunya

On November 5, GVN and its partner, ASTMH, convened a special symposium on “The Global Spread of Chikungunya: Epidemiology, Evolution, Pathogenesis and Global Needs” at the annual ASTMH meeting in New Orleans.  All three of GVN’s Task Force Chairs on Chikungunya spoke at the session, which was organized by Dr. Scott Weaver of UTMB, one of the co-chairs.  Other co-chairs are Dr. Marc Lecuit, Pasteur Institute, France, and Dr. John Fazakerley, Pirbright Institute, UK.  Click here for the full agenda.

MEDIA ADVISORY

By | News | No Comments

Who: The Windward Islands Research and Education Foundation (WINDREF) and St. George’s University (SGU) in partnership with the Global Virus Network (GVN)

  • Dr. Robert Gallo, Director, Institute of Human Virology, University of Maryland School of Medicine and Co-Founder and Scientific Director, GVN
  • Dr. Anders Vahlne, Professor of Clinical Virology at the Department of Laboratory Medicine, Karolinska Institute, and Center Director of the Swedish-Estonia GVN Center of Excellence
  • The Rt. Hon C. Modeste-Curwen, Minister of Health, Grenada
  • Calum N.L. Macpherson, Vice President and Founding Director, WINDREF
  • Dr.  Charles R. Modica, Chancellor, SGU

What: Virology Workshop for U.S. and Caribbean Journalists

When: 7:30 am, Thursday January 30, 2014 – 12:00 pm, Saturday February 1, 2014

Where: St. George’s University (SGU)

Contact: For more info, please contact Nora Grannell at ngrannell@gvn.org or 1 410-706-1966

Conference Overview:

The Viral Workshop for Journalists will provide reporters from varying U.S. and Caribbean media outlets an opportunity to learn firsthand about the nature of viruses, their spread, and virus treatments and vaccinations.  The workshop aims to take what can be a complex subject – the science and epidemiology of viruses – and break it down to a comprehensible level that can be utilized when reporters need to communicate to the masses about important news relating to viruses.  The workshop will feature expert virologists from around the world, including world renowned virologist Dr. Robert Gallo, most widely known for his co-discovery of HIV and his development of the blood test.  Dr. Gallo also discovered the first known human retroviruses (HTLV-1 and HTLV-2) which are endemic to regions in the Caribbean including Grenada.  Local officials including the Rt. Hon C. Modeste-Curwin, Minister of Health will open the meeting, and SGU students will engage with reporters in the laboratory, among other activities.

Other leading participants include Dr. Anders Vahlne, Professor of Clinical Virology in the Department of Laboratory Medicine, Karolinska Institute, and Center Director of the Swedish-Estonian GVN Center of Excellence; Dr. Calum MacPherson, Vice Provost at St. George’s University and Vice President of WINDREF; Dr. Donald Jungkind, Professor of Microbiology at St. George’s University Medical School; and Dr. Charles Modica, Chairman of the Board of Trustees and Chancellor of St. George’s University.

Prominent Virologist Stanley Plotkin Joins GVN as Senior Advisor

By | Board Members, News | No Comments
Dr.-Stanley-Plotkin-photo
Baltimore, MD: January 14, 2014 ;The Global Virus Network (GVN) is honored to have Dr. Stanley A. Plotkin, Emeritus Professor of the University of Pennsylvania and consultant to all of the major vaccine manufacturers, serve as a senior advisor. Dr. Plotkin is world renowned for his development of the rubella vaccine- now in standard use throughout the world, and has worked extensively on the development and application of other vaccines including polio, rabies, varicella, rotavirus and cytomegalovirus.
 
“I am happy to join such a distinguished group of virologists,” said Dr. Plotkin.
 
“Stan is one of the most experienced and wisest of virologists who will be invaluable to the GVN objectives,” said GVN co-founder and scientific director Dr. Robert Gallo.
 
“Stan’s encyclopedic knowledge of viruses and their modes of transmission will be of enormous help in guiding the Scientific Leadership Board of GVN when decisions have to be made to limit the expansion of existing epidemics or curb the outbreak of newly emerging viruses,” said fellow GVN co-founder, Dr. Reinhard Kurth, Chairman of the Foundation Council, Ernst Schering Foundation in Berlin, Germany.